Dr. Todd Haim of the National Cancer Institute SBIR Development Center describes the NCI’s SBIR and STTR programs, their structure, the Institute’s funding interests, and FAQs.

 

View Slide Deck

Dr. Meg Mooney of the National Cancer Institute discusses new initiatives to accelerate development of cancer therapies in the era of precision medicine.

 

View Slide Deck

Mr. Henry Ahn of the National Science Foundation speaks on the NSF’s SBIR and STTR programs.

 

View Slide Deck

The largest-ever gathering in the Australian life sciences!

International BioFest 2016 will be the largest-ever gathering in Australian life sciences, with three major conferences coming together in one week in one place as one integrated network. The event will be held from 24-27 October 2016 in Melbourne by AusBiotech.

Conferences include the 17th International Biotechnology Symposium (IBS 2016), presenting the most advanced topics in biotechnology, green chemistry and its related fields; AusBiotech 2016, Australia’s national life science conference; and Australia Biotech Invest, Australia’s life science investment showcase.

Delegates from the biotechnology, biopharmaceutical, life sciences, business, investment, research, academic and health sectors will gather to celebrate Australian and international life sciences and highlight Melbourne as one of the world’s great biotechnology hubs.

 

Register now                                                                               Find out more

 

FreeMind Group to discuss alternative funding

Ayal Ronen, Vice President, FreeMind Group, will be part of the panel discussing alternative funding, discussing how this flexible funding model can be used within the life science sector. Mr Ronen will be joined by Bill Best, Managing Director, On Market Book Builds, and Ross Curtin, CEO, WealthSpring International Group.

View the program

The FreeMind Group is proud to support the upcoming Trans-Pacific Health Science Dialogue!

Where: Boston, MA

When: September 28-29, 2016

 

Big Players Are Making Big Bets on Biopharma in Asia

  • Chinese investors representing more than $5.5B are looking for Trans-Pacific investments
  • Pfizer is investing $150M in a biologics plant in China
  • BMS expects Opdivo sales in Japan to exceed $1B
  • The Hangzhou Economic Development Area is investing $350M in a global biotech center

Can You Afford to Sit on the Sidelines?

The time to think about establishing, expanding or accelerating an Asian strategy is now. With a lineup of top Asia experts, the Trans-Pacific Health Sciences Dialogue will provide you with a solid grasp of Asian biopharma opportunities and today’s best strategies for market entry and growth. This two-day event provides critical insights you will not find at any other meeting.

 

EARLY REGISRATION ENDS SOON >>> SAVE $300!

For complete details and to register go to:

www.TransPacificHSD.com

The FreeMind Group is a proud supporter of AdvaMed 2016

Where: Minneapolis, MN

When: October 17-19, 2016

 

AdvaMed 2016 is the leading MedTech Conference in North America, bringing more than 1,000 companies together for business development, capital formation, world-class educational opportunities and networking. A “must attend” event featuring a diverse attendee list that includes influential policy-makers, executives and media, AdvaMed 2016 seeks to advance the industry from key perspectives through panel sessions, executive forums and more.

Learn more about the event at www.advamed2016.com.

 

FreeMind is proud to support RESI Boston 2016 and invites you to use discount code FREEMIND100 for $100 off registration!

WhenTuesday, September 13, 2016

Where: The Westin Copley Place, Boston, MA

The first Redefining Early Stage Investments (RESI) Conference took place on September 16, 2013, and three years later, following highly successful events in San Francisco, Houston and Toronto, RESI will return to Boston for the 10th RESI Conference. Life Science Nation (LSN) will be hosting the RESI Boston conference in collaboration with Johnson & Johnson Innovation, JLABS on September 13th, 2016.
RESI Boston is a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks including: Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more. Through the RESI Partnering system, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development.

 

Attend BioSpain 2016

Bilbao, Spain
September 28-30

The FreeMind Group is a Proud Supporter of Biospain 2016

BIOSPAIN 2016 is organized by ASEBIO, the Spanish Bioindustry Association and the Basque Government through the SPRI, the Basque Business Development Agency.

Biotech professionals from across Europe, America and Asia will converge on Biospain 2016 for a 3-day conference designed to explore innovation and biotech challenges. BIOSPAIN consists of a Trade Exhibition, an Investment Forum, a complete program of conferences and a partnering system provided by EBD Group’s partneringONE®.  Highlights from the program include workshops and conferenceslike CRISPR, Big Data, New models of Pharma Innovation through acquisition, Cross Borders Venture Capital Investments, VC Investment in Diagnostics & Medical Devices, Early Stage Investment, Cancer Immunotherapy, New Diagnostic Methods, Vaccines, Alzheimer, Food and Health, Public Policies to access Innovation, Bioeconomy, Nanobiotechnology, New Oncology Therapies, among others.

BIOSPAIN Investment Forum is an international event which allows international innovative biotechnology businesses to meet with an audience of leading biotech investors.
Companies seeking international finance or partners will have the opportunity to present their business project to an audience of top corporate funds, venture capital, business angels and crowd funding platforms.

The last edition: Biospain 2014
Following the success of previous editions, Biospain 2014 hosted 200 exhibitors, more than 850 companies and institutions and over 1.850 delegates from 37 countries. One-to-one business meetings rose to 3.327 (+20%) making Biospain one of the largest business & technology transfer partnering events in the world, ranked 5th in the year 2014.